ENVVENO MEDICAL DL-00001
enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease. The company's lead product is the VenoValve, a replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in … Read more
ENVVENO MEDICAL DL-00001 (5HJ) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, ENVVENO MEDICAL DL-00001 (5HJ) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
ENVVENO MEDICAL DL-00001 - Net Assets Trend (None–None)
This chart illustrates how ENVVENO MEDICAL DL-00001's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for ENVVENO MEDICAL DL-00001 (None–None)
The table below shows the annual net assets of ENVVENO MEDICAL DL-00001 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to ENVVENO MEDICAL DL-00001's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
ENVVENO MEDICAL DL-00001 Competitors by Market Cap
The table below lists competitors of ENVVENO MEDICAL DL-00001 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kumbi Corporation
KO:008870
|
$5.69 Million |
|
Gyrodyne Company of America Inc
NASDAQ:GYRO
|
$5.69 Million |
|
Spineguard
PA:ALSGD
|
$5.69 Million |
|
Momentus Inc
NASDAQ:MNTS
|
$5.69 Million |
|
HUDDLESTOCK FINTECH-0019
F:9JR
|
$5.69 Million |
|
Fiberweb (India) Limited
NSE:FIBERWEB
|
$5.68 Million |
|
Nusantara Voucher Distribution Tbk PT
JK:DIVA
|
$5.68 Million |
|
Auriginal Mining Corp.
V:AUME
|
$5.68 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ENVVENO MEDICAL DL-00001's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares ENVVENO MEDICAL DL-00001's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently ENVVENO MEDICAL DL-00001 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares ENVVENO MEDICAL DL-00001's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ENVVENO MEDICAL DL-00001 (5HJ) | €- | N/A | N/A | $5.69 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.30 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $42.41 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.72 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $620.14 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.29 Million |